Halozyme Therapeutics (HALO) Cash & Equivalents Growth (1y) (2011 - 2026)
Halozyme Therapeutics (HALO) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
988.88% |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
4.77% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
3.35% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Halozyme Therapeutics |
8.24 Bn |
7.92 Bn |
297.47 Mn |
75.67% |
| Date | Value |
|---|
| Mar 31, 2026 |
75.67% |
| Dec 31, 2025 |
15.51% |
| Sep 30, 2025 |
171.95% |
| Jun 30, 2025 |
-67.07% |
| Mar 31, 2025 |
7.11% |
| Dec 31, 2024 |
-2.13% |
| Sep 30, 2024 |
-43.73% |
| Jun 30, 2024 |
-15.06% |
| Mar 31, 2024 |
70.81% |
| Dec 31, 2023 |
-49.46% |
| Sep 30, 2023 |
86.35% |
| Jun 30, 2023 |
143.22% |
| Mar 31, 2023 |
-18.21% |
| Dec 31, 2022 |
97.27% |
| Sep 30, 2022 |
-70.07% |
| Jun 30, 2022 |
-79.66% |
| Mar 31, 2022 |
-76.41% |
| Dec 31, 2021 |
-19.62% |
| Sep 30, 2021 |
647.91% |
| Jun 30, 2021 |
234.54% |
